SLC7A11: the Achilles Heel of Tumor?

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Jul 23

PMID 39040097

Authors

Yulang Jiang

Mingyu Sun

Affiliations

Soon will be listed here.

Abstract

The non-natriuretic-dependent glutamate/cystine inverse transporter-system Xc- is composed of two protein subunits, SLC7A11 and SLC3A2, with SLC7A11 serving as the primary functional component responsible for cystine uptake and glutathione biosynthesis. SLC7A11 is implicated in tumor development through its regulation of redox homeostasis, amino acid metabolism, modulation of immune function, and induction of programmed cell death, among other processes relevant to tumorigenesis. In this paper, we summarize the structure and biological functions of SLC7A11, and discuss its potential role in tumor therapy, which provides a new direction for precision and personalized treatment of tumors.

Citing Articles

Decoding ferroptosis: transforming orthopedic disease management.

Huo G, Lin Y, Liu L, He Y, Qu Y, Liu Y Front Pharmacol. 2024; 15:1509172.

PMID: 39712490 PMC: 11659002. DOI: 10.3389/fphar.2024.1509172.

Intracellular Iron Deficiency and Abnormal Metabolism, Not Ferroptosis, Contributes to Homocysteine-Induced Vascular Endothelial Cell Death.

Shi W, Zhang J, Zhao W, Yue M, Ma J, Zeng S Biomedicines. 2024; 12(10).

PMID: 39457614 PMC: 11504269. DOI: 10.3390/biomedicines12102301.

Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1/SREBP1/SCD1 pathway.

Xie D, Jiang Y, Wang H, Zhu L, Huang S, Liu S Front Pharmacol. 2024; 15:1441105.

PMID: 39399463 PMC: 11470441. DOI: 10.3389/fphar.2024.1441105.

References

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

Liu M, Zhu W, Pei D . System Xc: a key regulatory target of ferroptosis in cancer. Invest New Drugs. 2021; 39(4):1123-1131. DOI: 10.1007/s10637-021-01070-0. View

Mou Y, Wang J, Wu J, He D, Zhang C, Duan C . Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019; 12(1):34. PMC: 6441206. DOI: 10.1186/s13045-019-0720-y. View

Okazaki S, Umene K, Yamasaki J, Suina K, Otsuki Y, Yoshikawa M . Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma. Cancer Sci. 2019; 110(11):3453-3463. PMC: 6825010. DOI: 10.1111/cas.14182. View

Nath P, Alfarsi L, El-Ansari R, Masisi B, Erkan B, Fakroun A . The amino acid transporter SLC7A11 expression in breast cancer. Cancer Biol Ther. 2023; 25(1):2291855. PMC: 10761065. DOI: 10.1080/15384047.2023.2291855. View

Menezes J, Diederich M . Bioactivity of natural biflavonoids in metabolism-related disease and cancer therapies. Pharmacol Res. 2021; 167:105525. DOI: 10.1016/j.phrs.2021.105525. View

Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F . The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020; 5(1):87. PMC: 7292831. DOI: 10.1038/s41392-020-0187-x. View

Li Y, Zeng X, Lu D, Yin M, Shan M, Gao Y . Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis. Hum Reprod. 2020; 36(4):951-964. DOI: 10.1093/humrep/deaa363. View

Long Y, Tao H, Karachi A, Grippin A, Jin L, Chang Y . Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma. Cancer Res. 2019; 80(3):499-509. DOI: 10.1158/0008-5472.CAN-19-1577. View

10.

Zheng P, Zhou C, Ding Y, Duan S . Disulfidptosis: a new target for metabolic cancer therapy. J Exp Clin Cancer Res. 2023; 42(1):103. PMC: 10134647. DOI: 10.1186/s13046-023-02675-4. View

11.

Yonezawa M, Back S, Gan X, Rosenberg P, Volpe J . Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor. J Neurochem. 1996; 67(2):566-73. DOI: 10.1046/j.1471-4159.1996.67020566.x. View

12.

Stockwell B, Jiang X . The Chemistry and Biology of Ferroptosis. Cell Chem Biol. 2020; 27(4):365-375. PMC: 7204503. DOI: 10.1016/j.chembiol.2020.03.013. View

13.

Li X, Li Y, Lian P, Lv Q, Liu F . Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma. Hum Exp Toxicol. 2023; 42:9603271221142818. DOI: 10.1177/09603271221142818. View

14.

Digomann D, Linge A, Dubrovska A . SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed. Autophagy. 2019; 15(10):1850-1851. PMC: 6735542. DOI: 10.1080/15548627.2019.1639302. View

15.

Koppula P, Zhang Y, Zhuang L, Gan B . Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018; 38(1):12. PMC: 5993148. DOI: 10.1186/s40880-018-0288-x. View

16.

Nachef M, Ali A, Almutairi S, Lee S . Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment. Front Immunol. 2021; 12:624324. PMC: 8089370. DOI: 10.3389/fimmu.2021.624324. View

17.

Wang L, Hinoi E, Takemori A, Nakamichi N, Yoneda Y . Glutamate inhibits chondral mineralization through apoptotic cell death mediated by retrograde operation of the cystine/glutamate antiporter. J Biol Chem. 2006; 281(34):24553-65. DOI: 10.1074/jbc.M600939200. View

18.

Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R . Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2015; 63(1):173-84. PMC: 4688087. DOI: 10.1002/hep.28251. View

19.

Saito Y, Soga T . Amino acid transporters as emerging therapeutic targets in cancer. Cancer Sci. 2021; 112(8):2958-2965. PMC: 8353895. DOI: 10.1111/cas.15006. View

20.

Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L . Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 2024; 5(4):572-589. DOI: 10.1038/s43018-023-00715-8. View